User-generated discussion. Not investment advice — verify claims against source filings.
Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.
2 active warrant series covering 23,171,440 shares (~17.1% potential dilution); nearest expiry 2027-12-04.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.75 | Dec 4, 2027 418d | 23.0M | ITM | 17.0% | C$17.3M | Auto |
| warrant | $0.60 | Dec 4, 2027 418d | 171K | ITM | 0.1% | C$103K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
5 option grants covering 8,365,000 shares (~6.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.19 | Jan 10, 2029 821d | 1.6M | ITM | 1.2% | C$314K | Auto |
| option | $0.19 | Apr 12, 2029 913d | 150K | ITM | 0.1% | C$29K | Auto |
| option | $0.28 | Feb 21, 2030 1228d | 1.2M | ITM | 0.9% | C$325K | Auto |
| option | $0.73 | Dec 8, 2030 1518d | 4.5M | ITM | 3.3% | C$3.3M | Auto |
| option | $0.98 | Mar 31, 2031 1631d | 875K | ITM | 0.6% | C$858K | Auto |
135,627,416 shares outstanding, plus 23,171,440 from warrants and 8,365,000 from options — a fully diluted 167,163,856 shares, or ~23.3% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.